PCSA

Processa Pharmaceuticals Inc

2.160

+0.200+10.20%

After Hours: 2.140 -0.020 -0.93%19:42 07/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.100/1.960

TODAY RANGE2.069-2.380

VOL205.29K

MARKET CAP5.98M

52 WEEK RANGE1.760-14.24

AVG VOL (3M)67.23K

% TURNOVER7.42%

TURNOVER--

P/E (TTM)-0.1982

% RANGE15.85%

EPS(TTM)-10.9007

P/E(FORWARD)-0.2009

P/B2.276

BVPS0.9489

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP5.12M

SHARES OUTSTANDING2.77M

NEXT EARNINGS08/05-08/10

FREE FLOAT2.37M

LOT SIZE1

EX-DATE12/17/2025

News

Press Releases

Financial Reports

Profile

PUBT·3d ago
Processa Pharma President of R&D David Young acquires 2,531 common shares worth $4,884.83
PUBT·06/18 20:07
Processa Pharmaceuticals announces annual shareholder meeting
Benzinga·06/16 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
PUBT·06/16 20:20
Processa Pharma Chief Administrative Officer Wendy Guy acquires 2,118 common shares worth $4,701.96
NASDAQ·06/12 03:54
Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...
Benzinga·06/10 21:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga·06/10 12:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
PUBT·06/01 21:02
Processa R&D President David Young reports purchase of 1,786 Processa shares for $4,590.02
PUBT·06/01 21:01
Processa CFO Russell Skibsted acquires 2,292 common shares for $5,890.44
PUBT·06/01 20:59
Processa Pharma CEO George Ng acquires 2,129 common shares for $5,471.53
PUBT·06/01 20:58
Processa chief business-strategy officer Patrick Lin acquires 1,582 shares for $4,065.74
PUBT·06/01 20:57
Processa Pharmaceuticals Chief Administrative Officer Wendy Guy acquires 1,829 common shares for $4,701.53
PUBT·05/19 22:06
Processa CEO George Ng buys 1,843 shares for $5,472.71
PUBT·05/19 22:05
Processa R&D President David Young acquires 1,545 shares worth $4,588.65
PUBT·05/19 22:02
Processa Chief Business-Strategy Officer Patrick Lin acquires 1,369 shares for $4,065.93

Same Industry

Name/Symbol

Change%

Price

Regeneron Pharmaceuticals

REGN

+0.05%

633.19

GridAI Tech

GRDX

+1.85%

4.410

BIONTECH

BNTX

-0.49%

93.80

United Therapeutics Corp.

UTHR

-0.13%

542.66

Vertex Pharmaceuticals Inc

VRTX

+2.32%

491.34

Siga Technologie

SIGA

-0.76%

3.920

Moderna

MRNA

+3.61%

69.70

Charles Riv Labs Intl Inc

CRL

+1.43%

215.75

Medpace Holdings

MEDP

+1.37%

527.07

Talphera Inc

TLPH

+0.97%

1.040

ICON plc

ICLR

-1.14%

173.06

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

+2.53%

191.14

MOLN

Arcturus Therape

ARCT

-0.87%

6.82

Gilead Sciences Inc

GILD

+3.26%

127.88

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

+0.40%

113.81

Aptevo Therapeutics Inc

APVO

-0.66%

4.550

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.